Drug intelligence / Profile preview

Baji Capsules

Development stage: Unknown
Lead developer: S&P Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Baji Capsules is a traditional Chinese medicine (TCM) product developed and manufactured by Chongqing Healn Pharmaceutical. The formulation is primarily derived from the root of *Morinda officinalis* (known as Bajitian in TCM). It is traditionally used to tonify the kidney yang, strengthen tendons and bones, and dispel wind and dampness. Clinical indications for this product typically include conditions associated with kidney yang deficiency, such as impotence, premature ejaculation, infertility, and chronic lower back or knee pain. The drug is administered orally in a capsule dosage form and is currently approved and marketed in China.

Brand names: 巴戟胶囊
Other names: Bajitian CapsulesMorinda officinalis Capsules

Targets

KEAP1 (Kelch-like ECH-associated protein 1)RAC1 (Rac family small GTPase 1)

Beyond the preview

Go deeper on Baji Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baji Capsules.

Explore the full profile